PTEN and breast carcinoma: recently reported that HINT3 inhibits the activation of the PTEN/AKT/mTOR signaling pathway, suppressing the proliferation, growth, migration, and tumor development of MCF‐7 and MDA‐MB‐231 breast cancer cells.